CD4 cell count response to nonnucleoside reverse transcriptase inhibitor- or protease inhibitor-based highly active antiretroviral therapy in an observational cohort study.

Source:http://linkedlifedata.com/resource/pubmed/id/14600584

J. Acquir. Immune Defic. Syndr. 2003 Nov 1 34 3 347-8

Download in:

View as

General Info

PMID
14600584